Phoenix A. Ho

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo et al. · Blood · 2012 · 293 citations · Full text

Medicine, Hematology, Oncology +17

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2009 · 216 citations · Full text

Medicine, Oncology, Pediatrics +12

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2010 · 183 citations · Full text

Medicine, Genetics, Molecular Genetics +11

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Eytan M. Stein, Roland B. Walter, Harry P. Erba et al. · Blood · 2017 · 180 citations · Full text

Medicine, Hematology, Oncology +11

Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients

Sioḃán Keel, Angela Scott, Marilyn Sánchez-Bonilla et al. · Haematologica · 2016 · 155 citations · Full text

Medicine, Genetics, Hematology +17